The global short-read sequencing market size is expected to reach USD 18.64 billion by 2025, at a 11.32% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Rising demand for personalized medicine and companion diagnostics is anticipated to drive the growth.
In
addition, initiatives taken by key players to enhance their market presence are
expected to boost revenue generation in the market for short-read sequencing.
For instance, in March 2019, Illumina partnered with Boai NKY Medical Holdings,
a China-based producer of polyvinylpyrrolidone, to develop NGS-based systems
for in-vitro diagnosis of hereditary diseases. The novel systems would be
developed by using NKY's library prep kits and analysis software and Illumina’s
MiniSeq system.
Other
major market players have also entered into partnerships and collaborations for
expansion in the Asian market as Asia Pacific offers a wide customer-base of
patients suffering from chronic disorders that can be diagnosed easily using
sequencing methods.
Major
application areas of short-read sequencing include reproductive screening,
oncology, noninvasive prenatal testing, infectious disease, and
pharmacogenomics. A rise in adoption of sequencing platforms for diagnosis of
the aforementioned clinical conditions is expected to have a positive impact on
the overall market growth.
Full Research Report On Short-read Sequencing Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/short-read-sequencing-market
Further key
findings from the report suggest:
- Next-generation Sequencing
(NGS) accounted for the largest revenue share in 2018 and is expected to
maintain its dominance over the forecast period, owing to the presence of
substantial platforms and services offered by prominent participants in
NGS is anticipated to add to the market revenue
- Consumables product segment
is expected to witness lucrative growth over the forecast period, since
these products are short-lived and exhibit higher usability
- Short read methods are most
commonly adopted in the field of oncology owing to an increase in the
adoption of NGS technology to advance personalized treatment for different
types of cancer
- Sequencing step dominated
with the largest market share in 2018 as it is the important step of the
protocols implemented in terms of time as well as consumables
- Academic research held the
largest market share in 2018 as a consequence of higher usage of these
protocols in research, academic workshops, and on-site bioinformatics
courses offered by universities
- Illumina, Inc.; Thermo
Fisher Scientific Inc.; 10x Genomics; and Qiagen N.V. are the prominent
participants operating in the short-read sequencing market. These
participants engage in new product development and strategic alliances to
maintain the market share
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/short-read-sequencing-market/request/rs1
Grand View Research has segmented
the global short-read sequencing market on the basis of technology, products,
application, workflow, end use, and region:
Short-read
Sequencing Technology Outlook (Revenue, USD Million, 2014 - 2025)
- Next-generation Sequencing
- Sanger Sequencing
Short-read
Sequencing Product Outlook (Revenue, USD Million, 2014 - 2025)
- Instruments
- Consumables
- Services
Short-read
Sequencing Application Outlook (Revenue, USD Million, 2014 - 2025)
- Oncology
- Clinical Investigation
- Reproductive Health
- HLA Typing/Immune System
Monitoring
- Metagenomics, Epidemiology
& Drug Development
- Agrigenomics & Forensics
- Consumer Genomics
Short-read
Sequencing Workflow Outlook (Revenue, USD Million, 2014 - 2025)
- Pre-Sequencing
- Sequencing
- Data Analysis
Short-read Sequencing
End Use Outlook (Revenue, USD Million, 2014 - 2025)
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharma & Biotech
Entities
- Other
Short-read
Sequencing Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- MEA
- South Africa
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment